Search Results 211-220 of 16947 for clindamycin

1. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

2. Treatment of Recurrent Clostridium Difficile Infection with RBX7455 - Mayo Clinic

   About this study. The purpose of this study is to demonstrate the efficacy and safety of RBX7455 (an oral microbiota based drug) for the treatment of ...

3. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

   This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...

4. Clotrimazole (topical route) - Side effects & dosage - Mayo Clinic

   This medicine is available both over-the-counter (OTC) and with your doctor's prescription. This product is available in the following dosage forms: Cream ...

5. Orquestando el cuidado (y cirugía robótica) para Cáncer de Próstata - Mayo Clinic

   Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

6. Tretinoin (topical route) - Side effects & dosage - Mayo Clinic

   It works partly by keeping skin pores clear. One of the tretinoin creams is used to treat fine wrinkles, dark spots, or rough skin on the face caused by the ...

7. Clinical trials - Oncology (Medical)

   The use of this lotion is considered investigational since it hasn't been studied in lymphoma cancer patients with low magnesium levels before; however, the FDA ...

8. A Study to Evaluate the Safety and Effectiveness of Lanadelumab to Prevent Acute Attacks of Non-histaminergic Angioedema - Mayo Clinic

   About this study. The purpose of this study is to evaluate the long-term safety and effectiveness of repeated subcutaneous (SC) administration of ...

9. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

   Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...

10. Mayo Clinic

    Share · Tweet. Nov. 06, 2014 . VID-20116660. Home; YouTube - Mayo Clinic Led Study on Long QT Syndrome Sheds Light on Genetic Testing ...